FDA Drug recall D-0208-2025
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma
- FDA Drug
- Class III
- completed
- Published 2025-01-29
On 2025-01-29 the FDA classified a Class III recall of Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma by Appco Pharma, citing failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0208-2025 |
| Classification | Class III |
| Status | completed |
| Initiated | 2025-01-16 |
| Published | 2025-01-29 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Appco Pharma |
| Distribution | US |
Product
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Reason
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Identifiers
| ndc | 43598-943-30 |
|---|---|
| ndc | 43598-943-90 |
| ndc | 43598-944-30 |
| ndc | 43598-944-90 |
| code_info | Lot #: 2402101UR, Exp 02/28/2027 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0208-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.